Buprenorphine Treatment
The Carlat Addiction Treatment Report, Volume 9, Number 7&8, November 2021
https://www.thecarlatreport.com/newsletter-issue/catrv9n7-8/
Issue Links: Learning Objectives | Editorial Information
Topics: Addiction Treatment | Buprenorphine | Buprenorphine Induction | Detoxification | Medication for Opioid Use Disorder (MOUD) | Opioid Use Disorder
Noah Capurso, MD
Assistant professor of psychiatry at Yale University, CT. Editor-in-chief of The Carlat Addiction Treatment Report.
Dr. Capurso has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Buprenorphine is a first line medication for the treatment of opioid use disorder yet remains vastly under-prescribed. Here, Dr. Capurso reviews the pharmacologic principles relevant to buprenorphine prescribing and lays out how to start patients on the medication both in the clinic and at home.
You can't view details of this content, please login or buy subscription here